Total planned funding: $624,819,012
Clear active filters
Chemonics International
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $137,489,988 |
Tanzania | $121,603,235 |
Zambia | $117,540,795 |
Mozambique | $55,580,018 |
Rwanda | $41,289,989 |
Zimbabwe | $33,636,684 |
Democratic Republic of the Congo | $19,787,449 |
Ethiopia | $16,825,781 |
Uganda | $16,407,361 |
Haiti | $12,429,765 |
Vietnam | $9,130,976 |
South Africa | $8,076,885 |
Kenya | $7,188,423 |
Ukraine | $6,348,771 |
Eswatini | $6,121,278 |
Lesotho | $2,000,000 |
Burundi | $1,815,830 |
Cameroon | $1,594,192 |
Namibia | $1,460,800 |
Botswana | $1,367,945 |
Indonesia | $1,300,000 |
Angola | $1,250,000 |
Ghana | $1,010,959 |
Central America Region | $921,400 |
South Sudan | $691,359 |
Malawi | $586,468 |
Caribbean Region | $512,660 |
Burma | $500,000 |
Cambodia | $350,000 |
Côte d'Ivoire | $1 |
Organizational Types
Private Contractor | $624,819,012 |
Program Areas
Treatment | $451,368,546 |
Testing | $55,913,601 |
Care | $52,501,617 |
Prevention | $33,587,204 |
Governance and Systems | $31,448,044 |
Budget Codes
HTXD: Treatment: ARV Drugs | $326,180,308 |
HTXS: Treatment: Adult Treatment | $114,326,649 |
HVCT: Testing: HIV Testing and Counseling | $55,913,601 |
OHSS: Health Systems Strengthening | $26,191,872 |
HBHC: Care: Adult Care and Support | $25,355,380 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $15,029,309 |
HVTB: Care: TB/HIV | $14,897,834 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $12,302,535 |
PDTX: Treatment: Pediatric Treatment | $10,861,589 |
HKID: Care: Orphans and Vulnerable Children | $8,617,461 |
HLAB: Laboratory Infrastructure | $3,676,137 |
PDCS: Care: Pediatric Care and Support | $3,630,942 |
HVOP: Sexual Prevention: Other Sexual Prevention | $2,942,203 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,138,157 |
HVSI: Strategic Information | $1,580,035 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $900,000 |
HMIN: Biomedical Prevention: Injection Safety | $275,000 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
Top Partner Programs
Chemonics International:
$624,819,012
View countries